Abstract
A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have